Diosgenin reduces phosphodiesterase 3B (PDE3B) through AMP-activated protein kinase/ mechanistic target of rapamycin (AMPK/mTOR) signaling pathway to ameliorate streptozotocin-induced pancreatic β-cell apoptosis and dysfunction

Diabetes mellitus is a metabolic disease caused by defective insulin secretion and/or insulin action. And insulin is the main hormone released by the pancreatic β-cells. Diosgenin (DG) is a phytochemical with pharmacological activity that increases insulin secretion in streptozotocin (STZ)-induced p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Lijie, Zhang, Chengfei, Wu, Lili, Qin, Lingling, Liu, Tonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973619/
https://www.ncbi.nlm.nih.gov/pubmed/35030973
http://dx.doi.org/10.1080/21655979.2021.2023996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973619/
https://www.ncbi.nlm.nih.gov/pubmed/35030973
http://dx.doi.org/10.1080/21655979.2021.2023996

Ejemplares similares